
部署於
正在使用Intuitive Surgical機器人的機構——來自部署紀錄。
公司簡介
https://www.intuitive.com/en-us/contact-us
機器人媒體與亮點
精選機器人影片
暫無精選機器人影片
暫無影片
該公司尚未關聯精選機器人影片。
機器人概覽
暫無主要機器人方向資訊。
相關新聞

Teleoperated Humanoid Robots Successfully Perform Laparoscopic Surgery in Animal Trials
A research team at UC San Diego has successfully used a teleoperated humanoid robot to perform laparoscopic gallbladder removal in pigs, as highlighted in Nature Medicine on July 31, 2026. The research demonstrates the feasibility of using general-purpose humanoid morphology with standard surgical instruments for complex procedures, challenging the dominance of purpose-built surgical robots like Intuitive Surgical's Da Vinci system and potentially enabling surgical access in standard operating rooms without specialized equipment.

Johnson & Johnson Wins FDA Authorization for OTTAVA, the First Table-Integrated Surgical Robot
The United States Food and Drug Administration has granted De Novo authorization to Johnson & Johnson's OTTAVA Robotic Surgical System, the first soft tissue surgical robot with arms built directly into the operating table, clearing it for ten general surgery procedures and setting up the first serious architectural challenge to Intuitive Surgical's long-standing dominance.

FDA Clears Versius Plus for Six Gynaecological Procedures
CMR Surgical's Versius Plus won FDA 510(k) clearance for six benign gynaecological procedures, but the clearance excludes monopolar scissors and arrives as Stryker takes over the company's US sales operation.

Stryker Invests US$400 Million in CMR Surgical, Takes US Sales Lead
Stryker is investing US$400 million in CMR Surgical, gaining an exclusive option to acquire the rest of the company and exclusive U.S. sales rights for its Versius soft-tissue surgical robot.
相關文章

J&J's OTTAVA Breaks Intuitive Surgical's Lock on the OR
Johnson & Johnson's first commercial OTTAVA installation, arriving days after Medtronic's Hugo cleared FDA review, turns surgical robotics from a one-vendor market into a genuine three-way contest with Intuitive Surgical's da Vinci.

What a 14-Million-Procedure Study Says About da Vinci
A 14-million-procedure meta-analysis backed by Intuitive Surgical finds da Vinci robotic surgery beats open surgery on complications and mortality but shows no advantage over laparoscopic surgery, a distinction hospital capital committees should weigh before expanding robotic capacity.

The U.S. Is No Longer the First Market a Surgical Robot Conquers
Medtronic's latest Hugo clearance covers one instrument for one U.S. specialty, four years after the platform launched abroad. Across surgical robotics, FDA clearance now proceeds one procedure at a time, and it's made the United States the last major market platforms reach with full capability.

The Surgical Robotics Shakeout: A Bankruptcy, a Duopoly Test, and the Buyer's New Leverage
Surgical robotics just lost one of its most hyped startups to bankruptcy in the same week the premium market gained its first credible second supplier in a generation. This analysis maps the consolidation economics deciding who survives, China's parallel game, and a practical evaluation framework for hospitals entering the duopoly era.

What Is Physical AI?
Most people think AI lives inside computers and phones. That is no longer true. The moment AI gained sensors, motors, and the ability to act in physical space, its mistakes stopped being reversible. This affects every worker, patient, infrastructure manager, and policymaker whose environment now includes a machine that can move and decide. The question no one is answering clearly enough is: what exactly is physical AI, and why does it change the stakes so fundamentally?
由以下公司打造的機器人 INTUITIVE SURGICAL
領導層
Gary Guthart (CEO)





